Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Magni

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Cancer Research|October 2, 2010
Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic deathRoberta Zappasodi, Serenella M Pupa, Gaia C Ghedini, et al.
Blood|January 17, 2004
Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizersCarmelo Carlo-Stella, Massimo Di Nicola, Raffaella Milani, et al.
Cancer|August 28, 2003
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3Alessandra Cuttica, Francesco Zallio, Marco Ladetto, et al.
Stem Cells (Dayton, Ohio)|September 30, 2006
Placental growth factor-1 potentiates hematopoietic progenitor cell mobilization induced by granulocyte colony-stimulating factor in mice and nonhuman primatesCarmelo Carlo-Stella, Massimo Di Nicola, Paolo Longoni, et al.
Blood|September 24, 2008
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot studyMassimo Di Nicola, Roberta Zappasodi, Carmelo Carlo-Stella, et al.
Leukemia Research|May 19, 2009
Radioimmunotherapy and secondary leukemia: a case reportMichele Magni, Massimo Di Nicola, Adele Testi, et al.
Cancer Research|April 6, 2007
IFN-gamma enhances the antimyeloma activity of the fully human anti-human leukocyte antigen-DR monoclonal antibody 1D09C3Carmelo Carlo-Stella, Anna Guidetti, Massimo Di Nicola, et al.
International Journal of Cancer|March 21, 2014
Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomasRoberta Zappasodi, Alessandra Cavanè, Marilena V Iorio, et al.
Blood|August 24, 2011
Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic targetRoberta Zappasodi, Italia Bongarzone, Gaia C Ghedini, et al.
Blood|January 16, 2010
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculatureCristiana Lavazza, Carmelo Carlo-Stella, Arianna Giacomini, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Cancer Research|October 2, 2010
Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic deathRoberta Zappasodi, Serenella M Pupa, Gaia C Ghedini, et al.
Blood|January 17, 2004
Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizersCarmelo Carlo-Stella, Massimo Di Nicola, Raffaella Milani, et al.
Cancer|August 28, 2003
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3Alessandra Cuttica, Francesco Zallio, Marco Ladetto, et al.
Stem Cells (Dayton, Ohio)|September 30, 2006
Placental growth factor-1 potentiates hematopoietic progenitor cell mobilization induced by granulocyte colony-stimulating factor in mice and nonhuman primatesCarmelo Carlo-Stella, Massimo Di Nicola, Paolo Longoni, et al.
Blood|September 24, 2008
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot studyMassimo Di Nicola, Roberta Zappasodi, Carmelo Carlo-Stella, et al.
Leukemia Research|May 19, 2009
Radioimmunotherapy and secondary leukemia: a case reportMichele Magni, Massimo Di Nicola, Adele Testi, et al.
Cancer Research|April 6, 2007
IFN-gamma enhances the antimyeloma activity of the fully human anti-human leukocyte antigen-DR monoclonal antibody 1D09C3Carmelo Carlo-Stella, Anna Guidetti, Massimo Di Nicola, et al.
International Journal of Cancer|March 21, 2014
Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomasRoberta Zappasodi, Alessandra Cavanè, Marilena V Iorio, et al.
Blood|August 24, 2011
Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic targetRoberta Zappasodi, Italia Bongarzone, Gaia C Ghedini, et al.
Blood|January 16, 2010
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculatureCristiana Lavazza, Carmelo Carlo-Stella, Arianna Giacomini, et al.
Pageof 5